How Companion Diagnostics Can Support Targeted Drug Launches
By Jane Li
September 29, 2026
Coordinated development and practical testing pathways can help ensure eligible patients are identified from the point of approval
5 min read
False
By Jane Li
September 29, 2026
Coordinated development and practical testing pathways can help ensure eligible patients are identified from the point of approval
5 min read
September 14, 2026
Scientists are already using AI in the lab – but many are doing so without the safeguards their employers may assume are in place
5 min read
September 3, 2026
Members of The Medicine Maker’s 2026 Power List predict how AI, new modalities, integrated data, and shifting global markets will reshape the industry
7 min read
By James Strachan
August 6, 2026
Six drug development leaders discuss smarter immunotherapy combinations, the enduring potential of small molecules, emerging modalities, and how cancer treatment could evolve over the next two decades
8 min read
By Adriana Stalteri
August 4, 2026
A recent multimillion-dollar freezer failure highlights the urgent need for real-time visibility across the pharmaceutical supply chain
4 min read
July 31, 2026
Nominations are now open for The Medicine Maker 2026 Innovation Awards, celebrating the latest technologies for drug development and manufacturing
1 min read
July 21, 2026
We celebrate 60 inspiring individuals helping turn pharma’s boldest ideas into reality
2 min read
By Crystal Allard, Pratyusha Pallavi
June 10, 2026
As new rules take hold, what does “good AI practice” look like in drug development?
6 min read
By Priya Baraniak
March 17, 2026
How 2025 marked biology’s shift toward engineering discipline
3 min read
By Yiannis Kiachopoulos
March 16, 2026
Organizations that benefit most from AI in R&D will be those that align technology with scientific reality
4 min read
False
False
False
Affiliations:
Specialties:
Areas of Expertise: